Vivera Pharmaceuticals is an innovative, science-driven pharmaceutical company located in Southern California. The Company has global exclusivity to license the patented and patent-pending TABMELT sublingual drug delivery system for pharmaceutical use and holds its own issued patents on ZICOH, a smart, dose-controlled electronic medical device, and MDZone, a portable telemedicine station. With multiple divisions, including its technologies, biosciences, medical devices, and advanced diagnostics divisions, Vivera Pharmaceuticals is vertically integrated with patented technology, manufacturing capabilities, and distribution for its products. From day one, Vivera's mission has been to put our patients first. From the opioid crisis to mental health and beyond, the Company strives to fulfill its purpose and promise toward product development and patient-centric research that puts the total health of the patient front and center.